NOTE enters into collaboration in medical technology
The product, My+Care™, is a wristband that uses artificial intelligence to analyse and monitor the user's health. By collecting data, risks can be predicted, and family members and carers informed, thereby preventing many injuries and accidents.
”Our investment in medical technology continues to be successful. This is a good example of a total solution where, by contributing expertise early in the process, we can support the customer so that the product reaches the market more quickly.”, says Per Ovrén, NOTE's President and CEO.
“CellMark sees NOTE as a long-term partner for developing and manufacturing medical devices. They take full responsibility for testing, sourcing and manufacturing life-saving solutions, which complements CellMark's business model as a global platform for medtech entrepreneurs,” says Niclas Möttus-Olsson, President CellMark Medical.
For further information, please contact:
Per Ovrén, President and CEO of NOTE, tel. 073-440 77 27
Henrik Nygren, CFO NOTE, tel. 070-977 06 86
Niclas Möttus-Olsson, President CellMark Medical, tel. 072-025 55 63
About NOTE
NOTE is one of northern Europe's leading manufacturing and logistics partners for the production of electronics-based products. NOTE manufactures printed circuit boards, sub-assemblies and complete products (box build). Its customer offering covers the whole product lifecycle, from design to after-sales. NOTE is established in Sweden, Finland, the UK, Estonia and China. Sales in the last 12 months totalled SEK 1,139 million, and the group has some 900 employees. NOTE is listed on Nasdaq Stockholm. For more information, please visit www.note.eu.
About CellMark
CellMark is a leader in international trade and business development for the global industry, offering services in sales & marketing, finance, logistics and business development. With a network of 70 offices in +30 countries, CellMark connects entrepreneurs across a wide range of industries. CellMark has 700 employees, an annual turnover of $3 billion and a trading volume of approximately 6.5 million tonnes. For more information, please visit www.cellmark.com.
IThe information was submitted for publication on 30 January 2018 at 08.30 CET.